Clinical Trials Directory

Trials / Completed

CompletedNCT01635140

Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children

Prospective Randomized Trial of Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Children's Cancer Hospital Egypt 57357 · Academic / Other
Sex
All
Age
3 Years – 18 Years
Healthy volunteers
Not accepted

Summary

Hypofractionated radiotherapy reduce the patient and family burden through decreasing the overall treatment time. This study is to evaluate the clinical end results of the hypofractionated radiotherapy in DIPG compared to the conventional treatment. The non-inferiority of the hypofractionated radiotherapy will result in decrease the hospital, stay or engagement, for more than its half with the same results.

Detailed description

In lack of open study protocols aiming to increase cure rate in pediatric diffuse intrinsic pontine glioma (DIPG), the investigators examined a hypofractionated radiotherapy regimen up to a dose of 39Gy in 13 fractions, completed in 2.5-3 weeks, instead of 6 weeks. This schedule offers a reduction in patient burden, especially preferable in children with a poor compliance and performance status. The non-inferiority of the hypofractionated regimen in its clinical end-results, with the reduction of the overall treatment time to less than its half will decrease the burden for the patient, his/her family and the treating department. This will be considered as added value without compromising the survival or increasing side effects.

Conditions

Interventions

TypeNameDescription
RADIATIONHypofractionated radiotherapyA total dose of 39 Gy in daily fractions of 3 Gy, 5 Fractions per week
RADIATIONConventional armA total dose of 54 Gy in 30 fractions giving 1.8 Gy per fraction.

Timeline

Start date
2010-05-01
Primary completion
2011-07-01
Completion
2011-07-01
First posted
2012-07-09
Last updated
2012-07-09

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT01635140. Inclusion in this directory is not an endorsement.